Cargando…
Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
Autores principales: | Chen, Wenxing, Pan, Yanhong, Wang, Siliang, Liu, Yuping, Chen, Guangying, Zhou, Liang, Zhang, Chao, Ni, Wenting, Wang, Aiyun, Lu, Yin, Huang, Shile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429697/ https://www.ncbi.nlm.nih.gov/pubmed/30902078 http://dx.doi.org/10.1186/s12885-019-5458-y |
Ejemplares similares
-
Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
por: Chen, Wenxing, et al.
Publicado: (2017) -
Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer
por: Pan, Yanhong, et al.
Publicado: (2017) -
Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer
por: Ni, Wenting, et al.
Publicado: (2021) -
The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back
por: Rehbein, Ulrike, et al.
Publicado: (2021) -
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
por: Carroll, Bernadette, et al.
Publicado: (2016)